Sodium Chloride Injection, Solution
Product Images NDC 64253-202

4 FDA label images from Medefil, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sodium Chloride (NDC 64253-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medefil, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Syringe-label (Syringe Label)

Syringe-label (Syringe Label)
Label of Sodium Chloride Injection, USP 0.9%, 10 mL fill in 12 mL syringe by Medefil, Inc. The label shows a 0.9% sodium chloride solution with 9 mg/mL for injection. It includes volume markings up to 12 mL on the syringe, a barcode, and states the product is sterile, nonpyrogenic, preservative-free, and latex-free. The label also notes its use as a sterile diluent and single-use instructions.*
FDA Label Image

Box-label (Box Label)

Box-label (Box Label)
Packaging label for Sodium Chloride Injection, USP 0.9%, 10 mL fill in 12 mL syringe, manufactured by Medefil, Inc. The label states the product contains 9 mg/mL sodium chloride as a sterile diluent, preservative-free, not made with natural rubber latex. It is indicated for single use only and is supplied in a carton of 60 syringes. Storage instructions and warnings about solution clarity are also displayed.*
FDA Label Image

L4061r004page2 (L4061r004page2)

L4061r004page2 (L4061r004page2)
This text panel includes sections on adverse reactions, drug interactions, product description, clinical pharmacology, supply and storage, and patient counseling information for Sodium Chloride Injection, USP 0.9%. It details the product's formulation, compatibility concerns, handling instructions, packaging in single-use syringes, and storage conditions.*
FDA Label Image

L4061r004page1 (L4061r004page1)

L4061r004page1 (L4061r004page1)
Prescribing information highlights for Sodium Chloride Injection USP 0.9%, including indications for dilution or dissolution of drugs for intravenous, intramuscular, or subcutaneous injection. The document covers dosage and administration, dosage form and strength (0.9% injection), contraindications (none), warnings, precautions, adverse reactions, drug interactions, and patient counseling information, along with detailed instructions for use and handling.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.